To elucidate the immune evasion mechanisms of SCCs, we established a transplanted tumor model using tumor cells derived from primary K15.KrasG12D.Smad4−/− SCCs [11] (hereafter referred to as KRS-SCCs). This evidence concerns the gene SMAD4 and neoplasm.